Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Pfizer vet takes CEO post at new, phase 3-ready biotech
Months after leaving Pfizer, Suneet Varma has taken the CEO position at the newly created inflammation and immunology startup Intent Biologics.
Nick Paul Taylor
Sep 9, 2025 10:03am
Capricor responds to cell therapy snub, disputes FDA’s concerns
Sep 9, 2025 11:44am
Novartis spends $1.4B for Tourmaline, CV med that wowed in ph. 2
Sep 9, 2025 4:28am
Lilly invites biotechs to use AI platform to develop their drugs
Sep 9, 2025 7:43am
Surgical robot maker Ronovo raises $67M with J&J backing
Sep 9, 2025 2:00pm
OraSure sees investor pressure, potential proxy fight: report
Sep 9, 2025 12:00pm
More News
Fierce Biotech Layoff Tracker 2025: Lundbeck, AC Immune & more
Sep 9, 2025 9:30am
LB Pharmaceuticals eyes $228M in IPO cash
Sep 8, 2025 3:16pm
FDA clears Microbot’s remote-controlled cath lab system
Sep 8, 2025 11:45am
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
Sep 8, 2025 11:00am
See more stories